Finance

Lists
Why is 4519 up ၃.၇၆%?
Dive Deeper
4519:TYO
Chugai Pharmaceutical Co Ltd
၆,၂၆၇.၀၀ JP¥
+၃.၇၆%
(+၂၂၇.၀၀) 1D
အောက် ၁၅, GMT+၉ ၁၅:၃၀:၀၀  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4519...
Open
၆,၁၄၀ JP¥
High
၆,၂၈၅ JP¥
Low
၆,၀၉၉ JP¥
Mkt. cap
ဋေ ၁.၀၅ သန်း
Avg. vol.
၂.၉၆ သန်း
Volume
၅.၂၀ သန်း
Dividend
၂.၂၀%
Quarterly dividend
၃၅ JP¥
Ex-dividend date
၂၀၂၆ ဇွန် ၂၉
P/E ratio
၂၁.၈၈
52-wk high
၁၀,၇၀၀ JP¥
52-wk low
၅,၉၇၄ JP¥
EPS
၂၈၆ JP¥
Shares outstanding
၅၄.၇၂ ကုဋေ
No. of employees
၅ ထောင်
Open
၆,၁၄၀ JP¥
High
၆,၂၈၅ JP¥
Low
၆,၀၉၉ JP¥
Mkt. cap
ဋေ ၁.၀၅ သန်း
Avg. vol.
၂.၉၆ သန်း
Volume
၅.၂၀ သန်း
Dividend
၂.၂၀%
Quarterly dividend
၃၅ JP¥
Ex-dividend date
၂၀၂၆ ဇွန် ၂၉
P/E ratio
၂၁.၈၈
52-wk high
၁၀,၇၀၀ JP¥
52-wk low
၅,၉၇၄ JP¥
EPS
၂၈၆ JP¥
Shares outstanding
၅၄.၇၂ ကုဋေ
No. of employees
၅ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၅ နာရီ
Chugai reports vamikibart data. Chugai Pharmaceutical stock costs EUR 35.28
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees၅.၁ ထောင်
Founded၁၉၂၅ မတ် ၁၀
Headquarters-
Sector-
Next call ၁၂ ရက်အတွင်း
အောက် ၂၇ အင်္ဂါ, ၁၁:၀၀
Fiscal period
Q3 2026
- / -
Revenue / Est. (JPY)
- / ဋေ ၃.၄၉ သ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၃.၃၃ သ
ဋေ ၃.၄၆ သ
ဋေ ၃.၂၂ သ
ဋေ ၃.၄၂ သ
Cost of goods sold
ဋေ ၁.၀၀ သ
ဋေ ၈.၇၆ ထ
ဋေ ၉.၂၈ ထ
ဋေ ၁.၀၄ သ
Cost of revenue
ဋေ ၁.၀၀ သ
ဋေ ၈.၇၆ ထ
ဋေ ၉.၂၈ ထ
ဋေ ၁.၀၄ သ
Research and development expenses
ဋေ ၄.၈၆ ထ
ဋေ ၅.၂၄ ထ
ဋေ ၄.၁၉ ထ
ဋေ ၄.၇၈ ထ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၂.၇၉ ထ
ဋေ ၃.၆၉ ထ
ဋေ ၂.၈၉ ထ
ဋေ ၂.၉၀ ထ
Operating expense
ဋေ ၇.၆၅ ထ
ဋေ ၈.၉၇ ထ
ဋေ ၇.၀၂ ထ
ဋေ ၇.၆၅ ထ
Total operating expenses
ဋေ ၁.၇၇ သ
ဋေ ၁.၇၇ သ
ဋေ ၁.၆၃ သ
ဋေ ၁.၈၁ သ
Operating income
ဋေ ၁.၅၆ သ
ဋေ ၁.၆၉ သ
ဋေ ၁.၅၉ သ
ဋေ ၁.၆၁ သ
Other non operating income
-၃၅.၆၀ ကုဋေ
၉၉.၄၀ ကုဋေ
၁၄၃.၂၀ ဋေ
၃၀၃.၅၀ ဋေ
EBT including unusual items
ဋေ ၁.၅၆ သ
ဋေ ၁.၇၀ သ
ဋေ ၁.၆၀ သ
ဋေ ၁.၆၉ သ
EBT excluding unusual items
ဋေ ၁.၅၆ သ
ဋေ ၁.၇၀ သ
ဋေ ၁.၆၀ သ
ဋေ ၁.၆၉ သ
Income tax expense
ဋေ ၄.၄၉ ထ
ဋေ ၄.၁၅ ထ
ဋေ ၄.၄၈ ထ
ဋေ ၅.၂၇ ထ
Effective tax rate
၂၈.၇၄%
၂၄.၄၂%
၂၇.၉၅%
၃၁.၁၇%
Other operating expenses
-၃.၈၀ ကုဋေ
၄၀.၅၀ ကုဋေ
-၅၉.၆၀ ကုဋေ
-၂၉.၁၀ ကုဋေ
Net income
ဋေ ၁.၁၁ သ
ဋေ ၁.၂၈ သ
ဋေ ၁.၁၅ သ
ဋေ ၁.၁၆ သ
Net profit margin
၃၃.၃၈%
၃၇.၀၈%
၃၅.၈၇%
၃၄.၀၆%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
၅၁၃.၁၀ ဋေ
Interest expense
-၅.၈၀ ကုဋေ
-၉.၅၀ ကုဋေ
-
-
Net interest expenses
-၅.၈၀ ကုဋေ
-၉.၅၀ ကုဋေ
-
၅၁၃.၁၀ ဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
ဋေ ၁.၅၇ သ
ဋေ ၂.၀၀ သ
ဋေ ၁.၅၉ သ
ဋေ ၁.၆၂ သ
Gain or loss from assets sale
-
၄၅၂.၇၀ ဋေ
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ